BUDAPEST, June 30 Hungarian drug maker Richter has acquired Swiss-based biotech company Finox Holding for 190 million Swiss francs ($193.86 million), expanding its presence in major European markets, Richter said in a statement on Thursday.
Richter, which makes gynaecological, cardiovascular and central nervous system drugs, also said it had obtained global rights for Finox female infertility medicine BEMFOLA, which received marketing authorisation in the European Union in May 2014.
Also read: France’s Choice: Le Divorce?
13:30 After French vote, European leaders come out against Le Pen. But what if she wins?22
12:22 French election result gives markets a start-of-week lift24
21:25 Macron’s success in France signals hope for unifying outsiders19
11:52 French regulator says up to 4,100 children victims of epilepsy drug29